| | 
Part, Chapter, Paragraph
1 II, 5. 5. 3| not in remission had a 9.3 RR of death (95% CI 3.8-22.
2 II, 5. 5. 3| seizure-related accidents (rate ratio, RR 1.8)(Vaa, 2005) and the
3 II, 5. 5. 3| risk of serious accidents (RR 1.4)(Taylor et al, 1996)
4 II, 5. 5. 3| secondary-progressive MS (SP-MS), initial RR course followed by progression
5 II, 5. 5. 3| PR courses are lumped to RR or PP ones.~ ~Disability~
6 II, 5. 8.Acr| RI~Respiratory Infections~RR~Relative Risk~VC~Vital Capacity~
7 II, 5. 8. 3| pneumonia (relative risk (RR) = 16.0), osteoporosis (
8 II, 5. 8. 3| 16.0), osteoporosis (RR = 3.1), RI (RR = 2.2), MI (
9 II, 5. 8. 3| osteoporosis (RR = 3.1), RI (RR = 2.2), MI (RR = 1.7), angina (
10 II, 5. 8. 3| 3.1), RI (RR = 2.2), MI (RR = 1.7), angina (RR = 1.7),
11 II, 5. 8. 3| MI (RR = 1.7), angina (RR = 1.7), fractures (RR =
12 II, 5. 8. 3| angina (RR = 1.7), fractures (RR = 1.6), and glaucoma (RR =
13 II, 5. 8. 3| RR = 1.6), and glaucoma (RR = 1.3) [all p <0.05].~ ~
14 II, 5. 9. FB| increase in relative risk (RR 1.5, 95% CI 1.2 to 1.8).
15 II, 5. 9. FB| subsequent asthma had a pooled RR of 1.2 (95% CI 1.1 to 1.
16 II, 5. 9. 4| in 1989: relative risk (RR) 1.32 (1.12, 1.56), even
17 II, 5. 9. 4| eczema and/or hay fever RR 1.20 (0.99, 1.45). By 2004
18 II, 5. 9. 4| diagnosis was no longer present, RR 1.01 (0.91, 1.12) for wheeze
19 II, 5. 9. 4| products, or chemical spills (RR=3.3, 95% CI 1.0-11.1, P=
|
|
| |
